Outpatient Parenteral Antimicrobial Therapy (OPAT)
NCT03221140 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2023-12-15
Summary
Outpatient parenteral antimicrobial therapy (OPAT) has been recognised as a useful, cost-effective and safe alternative to inpatient treatment, but no formal OPAT unit existed in Switzerland until recently. In December 2013 an OPAT unit was established at Lausanne University Hospital. The investigators plan to investigate the efficacy, safety and economicity of outpatient parenteral antimicrobial therapy administered at the new OPAT unit of the Lausanne University Hospital starting in January 2014 until December 2020.
Conditions
Interventions
- DRUG
-
Outpatient parenteral antimicrobial therapy
Administration of intravenous antimicrobials on an outpatient basis
Sponsors & Collaborators
-
University of Lausanne Hospitals
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
NCT00786305 ·Status: COMPLETED ·Phase: PHASE2
-
RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg
NCT00552799 ·Status: COMPLETED ·Phase: PHASE4
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Antibiotic Durations for Gram-negative Bacteremia
NCT03101072 ·Status: COMPLETED ·Phase: NA
-
Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration
NCT01171547 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis
NCT03681431 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia
NCT03163446 ·Status: COMPLETED ·Phase: PHASE2
-
Early Oral Switch for Uncomplicated Gram-negative Bacteraemia
NCT05199324 ·Status: RECRUITING ·Phase: PHASE4
-
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
NCT04434300 ·Status: COMPLETED ·Phase: PHASE1
-
Cellulitis Optimal Antibiotic Treatment
NCT05584007 ·Status: RECRUITING ·Phase: PHASE3
-
Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.
NCT07247942 ·Status: COMPLETED ·Phase: PHASE1
-
Short Against Long Antibiotic Therapy for Infected Orthopedic Sites
NCT05499481 ·Status: COMPLETED ·Phase: PHASE3
-
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
NCT03790631 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy
NCT00214331 ·Status: COMPLETED
-
S. Aureus Decolonization in HPN Patients.
NCT03173053 ·Status: TERMINATED ·Phase: NA
-
Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis
NCT03012360 ·Status: TERMINATED ·Phase: PHASE4
-
Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).
NCT03481569 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic
NCT00950222 ·Status: COMPLETED ·Phase: NA
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment
NCT01559753 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
NCT00583531 ·Status: TERMINATED ·Phase: PHASE2
-
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
NCT06738771 ·Status: RECRUITING
-
Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections
NCT03094494 ·Status: COMPLETED
-
Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
NCT00507247 ·Status: COMPLETED ·Phase: PHASE2
-
Beta-lactam Therapeutic Drug Monitoring in Singapore
NCT04450680 ·Status: UNKNOWN